Impact of lung and heart immaturity when investigating medicinal products intended for neonatal use

  • Email
  • Help
Current version

Concept paper

Reference numberEMEA/CHMP/PEG/114218/06
Published18/11/2015
KeywordsNeonates, medicines, drugs, developmental pharmacology, adreno-receptors, immaturity, lung, heart, surfactant
DescriptionThis document specifically discusses the impact of lung and heart immaturity when investigating medicinal products in term and preterm newborns and infants.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more